Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-13 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Eosinophilic Esophagitis 2 D057765 ClinicalTrials
Rhinitis, Allergic, Seasonal 2 D006255 ClinicalTrials
Scleroderma, Systemic 2 D012595 ClinicalTrials
Idiopathic Pulmonary Fibrosis 2 D054990 ClinicalTrials
Crohn Disease 2 D003424 ClinicalTrials
Keloid 2 D007627 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Pulmonary Fibrosis 2 D011658 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109465